Fen Yang Selected Research

Glucagon-Like Peptide 1 (GLP 1)

9/2016	Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.
1/2016	Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fen Yang Research Topics

Disease

59	Neoplasms (Cancer) 03/2024 - 08/2009
9	Breast Neoplasms (Breast Cancer) 01/2020 - 08/2009
8	Inflammation (Inflammations) 02/2024 - 01/2019
7	Infections 01/2024 - 11/2010
7	Stomach Neoplasms (Stomach Cancer) 10/2023 - 01/2017
7	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2009
5	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 07/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2016
4	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2016
4	Wounds and Injuries (Trauma) 01/2018 - 02/2016
3	Body Weight (Weight, Body) 01/2024 - 01/2021
3	Multiple Sclerosis 07/2023 - 09/2014
3	Rheumatoid Arthritis 01/2023 - 11/2016
3	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 07/2015
3	Nasopharyngeal Carcinoma 03/2015 - 01/2013
2	COVID-19 05/2024 - 11/2020
2	Atherosclerosis 02/2024 - 09/2022
2	Tuberculosis (Tuberculoses) 08/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 06/2023 - 06/2018
2	Lung Neoplasms (Lung Cancer) 03/2023 - 11/2019
2	Mental Disorders (Mental Disorder) 01/2023 - 01/2023
2	Myocardial Infarction 09/2022 - 01/2016
2	Neutropenia 01/2022 - 01/2021
2	Genomic Instability 01/2022 - 01/2012
2	Hypertension (High Blood Pressure) 01/2021 - 09/2016
2	Blast Injuries 03/2017 - 12/2016
2	Necrosis 01/2016 - 01/2016
2	Liver Neoplasms (Liver Cancer) 01/2016 - 07/2013
2	Prostatic Neoplasms (Prostate Cancer) 04/2015 - 11/2013
2	Mycoses (Diseases, Fungus) 11/2011 - 11/2010
1	Atherosclerotic Plaque (Atheroma) 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2024

Drug/Important Bio-Agent (IBA)

9	Long Noncoding RNAIBA 10/2023 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2010
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 07/2010
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2015
7	CytokinesIBA 10/2023 - 01/2014
7	Liposomes (Liposome)IBA 01/2023 - 02/2013
5	SeleniumIBA 01/2022 - 02/2013
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 02/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2016
4	hirsutanol AIBA 02/2013 - 07/2010
3	BilirubinIBA 01/2024 - 01/2021
3	InterleukinsIBA 10/2023 - 02/2016
3	EnzymesIBA 07/2023 - 01/2022
3	Bortezomib (Velcade)FDA Link 01/2023 - 10/2018
3	ProteomeIBA 01/2023 - 02/2010
3	Blood Glucose (Blood Sugar)IBA 01/2023 - 09/2016
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2022 - 01/2021
3	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2016
3	AntigensIBA 01/2021 - 09/2017
3	Phosphotransferases (Kinase)IBA 01/2021 - 08/2012
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2013
3	FlavonoidsIBA 07/2018 - 11/2014
3	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 02/2013
3	oridoninIBA 11/2017 - 01/2015
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2015 - 08/2012
3	TOR Serine-Threonine KinasesIBA 03/2015 - 08/2012
2	CollagenIBA 02/2024 - 01/2016
2	Uric Acid (Urate)IBA 01/2024 - 01/2020
2	Interleukin-13IBA 10/2023 - 01/2021
2	Chlorogenic AcidIBA 10/2023 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2016
2	Therapeutic UsesIBA 07/2023 - 01/2023
2	Silicon Dioxide (Silica)FDA LinkGeneric 03/2023 - 01/2023
2	Death Domain ReceptorsIBA 01/2023 - 12/2022
2	GlucocorticoidsIBA 01/2023 - 11/2018
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
2	LigandsIBA 01/2023 - 01/2023
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2017
2	simmitecanIBA 01/2022 - 11/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 08/2016
2	AntioxidantsIBA 01/2022 - 08/2014
2	CurcuminIBA 12/2021 - 07/2013
2	ProdrugsIBA 10/2021 - 10/2018
2	Liraglutide FDA Link 01/2021 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 02/2016
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018 - 12/2017
2	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2016 - 01/2016
2	Ursolic AcidIBA 08/2016 - 01/2016
2	ChitosanIBA 08/2016 - 01/2016
2	U 0126 (UO 126)IBA 04/2016 - 08/2012
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2016 - 08/2012
2	Mitogen-Activated Protein KinasesIBA 04/2016 - 08/2012
2	QuercetinIBA 03/2016 - 08/2014
2	ApigeninIBA 01/2016 - 11/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016 - 02/2013
2	N- (1- amino- 3- (2,4- dichlorophenyl)propan- 2- yl)- 2- (2- (methylamino)pyrimidin- 4- yl)thiazole- 5- carboxamideIBA 03/2015 - 08/2012
2	dactolisibIBA 03/2015 - 01/2013
2	SesquiterpenesIBA 02/2013 - 07/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024
1	alpha-hydroxyglutarateIBA 03/2024
1	LipidsIBA 02/2024
1	XanthineIBA 01/2024
1	Allopurinol (Remid)FDA LinkGeneric 01/2024

Therapy/Procedure

24	Therapeutics 01/2024 - 02/2013
3	Photochemotherapy (Photodynamic Therapy) 12/2022 - 01/2021
2	Intravenous Administration 01/2023 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018